Rybelsus (Semaglutide) 14 mg is an oral medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It belongs to the class of GLP-1 receptor agonists, which help stimulate insulin release and reduce glucagon secretion, thereby lowering blood glucose levels.
This pack contains 60 tablets, providing a two-month supply based on typical once-daily dosing.
Indications:
-
Management of type 2 diabetes as part of a comprehensive treatment plan including diet and exercise
-
May aid in weight reduction in conjunction with diabetes management
-
Can be used alone or with other antidiabetic agents
Dosage & Administration:
-
Take once daily, at least 30 minutes before the first food, beverage, or other oral medications
-
Swallow tablet whole with no more than a sip of water
-
Follow healthcare provider instructions for dose escalation and monitoring
Storage:
-
Store at room temperature (20–25°C / 68–77°F)
-
Keep tablets in the original container to protect from moisture
-
Keep out of reach of children
Warnings & Precautions:
-
Not for use in patients with type 1 diabetes or diabetic ketoacidosis
-
Possible side effects: nausea, vomiting, diarrhea, decreased appetite, abdominal pain
-
Monitor for signs of pancreatitis or allergic reactions
-
Inform healthcare provider about any history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
